Clinical Trial Update: Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on cadonilimab combined with CapeOX for perioperative treatment of resectable locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unresectable Gastric Adenocarcinoma

Drugs mentioned

• CAPEOX regimen
• Cadonilimab

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Locally Advanced Unresectable Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN